nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—gout—psoriatic arthritis	0.646	1	CtDrD
Probenecid—ABCC11—Methotrexate—psoriatic arthritis	0.0519	0.16	CbGbCtD
Probenecid—ALB—Auranofin—psoriatic arthritis	0.0254	0.0782	CbGbCtD
Probenecid—SLC16A1—Methotrexate—psoriatic arthritis	0.0228	0.0701	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—psoriatic arthritis	0.0228	0.0701	CbGbCtD
Probenecid—SLCO1A2—Prednisolone—psoriatic arthritis	0.0166	0.051	CbGbCtD
Probenecid—SLCO1A2—Prednisone—psoriatic arthritis	0.0157	0.0482	CbGbCtD
Probenecid—ABCC3—Methotrexate—psoriatic arthritis	0.0143	0.0441	CbGbCtD
Probenecid—SLC22A11—Methotrexate—psoriatic arthritis	0.0118	0.0362	CbGbCtD
Probenecid—SLC22A7—Methotrexate—psoriatic arthritis	0.0112	0.0345	CbGbCtD
Probenecid—ABCC4—Methotrexate—psoriatic arthritis	0.011	0.0337	CbGbCtD
Probenecid—SLCO1A2—Dexamethasone—psoriatic arthritis	0.00978	0.0301	CbGbCtD
Probenecid—ABCC1—Methotrexate—psoriatic arthritis	0.0088	0.0271	CbGbCtD
Probenecid—ABCC2—Dexamethasone—psoriatic arthritis	0.00811	0.0249	CbGbCtD
Probenecid—ALB—Prednisone—psoriatic arthritis	0.00809	0.0249	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—psoriatic arthritis	0.00786	0.0242	CbGbCtD
Probenecid—ABCB1—Methylprednisolone—psoriatic arthritis	0.00699	0.0215	CbGbCtD
Probenecid—SLC22A8—Methotrexate—psoriatic arthritis	0.00684	0.021	CbGbCtD
Probenecid—PANX1—The NLRP3 inflammasome—MEFV—psoriatic arthritis	0.00656	0.418	CbGpPWpGaD
Probenecid—ABCC2—Methotrexate—psoriatic arthritis	0.00651	0.02	CbGbCtD
Probenecid—CYP2C19—Prednisone—psoriatic arthritis	0.00525	0.0161	CbGbCtD
Probenecid—SLC22A6—Methotrexate—psoriatic arthritis	0.00477	0.0147	CbGbCtD
Probenecid—ABCB1—Betamethasone—psoriatic arthritis	0.00454	0.014	CbGbCtD
Probenecid—ABCB1—Prednisolone—psoriatic arthritis	0.00448	0.0138	CbGbCtD
Probenecid—PANX1—Inflammasomes—MEFV—psoriatic arthritis	0.00436	0.278	CbGpPWpGaD
Probenecid—ABCB1—Prednisone—psoriatic arthritis	0.00423	0.013	CbGbCtD
Probenecid—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00419	0.0129	CbGbCtD
Probenecid—ALB—Methotrexate—psoriatic arthritis	0.00406	0.0125	CbGbCtD
Probenecid—CYP2C8—Dexamethasone—psoriatic arthritis	0.0039	0.012	CbGbCtD
Probenecid—CYP2C19—Dexamethasone—psoriatic arthritis	0.00327	0.0101	CbGbCtD
Probenecid—CYP3A4—Triamcinolone—psoriatic arthritis	0.00317	0.00975	CbGbCtD
Probenecid—CYP2C9—Dexamethasone—psoriatic arthritis	0.00272	0.00837	CbGbCtD
Probenecid—CYP3A4—Betamethasone—psoriatic arthritis	0.00272	0.00837	CbGbCtD
Probenecid—CYP3A4—Prednisolone—psoriatic arthritis	0.00269	0.00826	CbGbCtD
Probenecid—ABCB1—Dexamethasone—psoriatic arthritis	0.00264	0.00812	CbGbCtD
Probenecid—CYP3A4—Prednisone—psoriatic arthritis	0.00254	0.0078	CbGbCtD
Probenecid—ABCB1—Methotrexate—psoriatic arthritis	0.00212	0.00653	CbGbCtD
Probenecid—PANX1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—psoriatic arthritis	0.0021	0.133	CbGpPWpGaD
Probenecid—SLC2A9—skeletal joint—psoriatic arthritis	0.00183	0.697	CbGeAlD
Probenecid—CYP3A4—Dexamethasone—psoriatic arthritis	0.00158	0.00487	CbGbCtD
Probenecid—Nephrotic syndrome—Auranofin—psoriatic arthritis	0.00155	0.155	CcSEcCtD
Probenecid—PANX1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—psoriatic arthritis	0.000789	0.0502	CbGpPWpGaD
Probenecid—Aplastic anaemia—Auranofin—psoriatic arthritis	0.000702	0.0703	CcSEcCtD
Probenecid—Haematuria—Auranofin—psoriatic arthritis	0.000399	0.0399	CcSEcCtD
Probenecid—Alopecia—Auranofin—psoriatic arthritis	0.000332	0.0332	CcSEcCtD
Probenecid—Anaemia—Auranofin—psoriatic arthritis	0.000302	0.0303	CcSEcCtD
Probenecid—PANX1—Innate Immune System—MEFV—psoriatic arthritis	0.000296	0.0189	CbGpPWpGaD
Probenecid—Leukopenia—Auranofin—psoriatic arthritis	0.000293	0.0293	CcSEcCtD
Probenecid—Anorexia—Auranofin—psoriatic arthritis	0.000254	0.0255	CcSEcCtD
Probenecid—PANX1—tendon—psoriatic arthritis	0.000232	0.0883	CbGeAlD
Probenecid—Decreased appetite—Auranofin—psoriatic arthritis	0.000232	0.0232	CcSEcCtD
Probenecid—Urticaria—Auranofin—psoriatic arthritis	0.000212	0.0212	CcSEcCtD
Probenecid—Pruritus—Auranofin—psoriatic arthritis	0.000189	0.0189	CcSEcCtD
Probenecid—PANX1—Immune System—MEFV—psoriatic arthritis	0.000173	0.011	CbGpPWpGaD
Probenecid—Vomiting—Auranofin—psoriatic arthritis	0.00017	0.017	CcSEcCtD
Probenecid—Dermatitis—Auranofin—psoriatic arthritis	0.000168	0.0168	CcSEcCtD
Probenecid—Nausea—Auranofin—psoriatic arthritis	0.000158	0.0159	CcSEcCtD
Probenecid—PANX1—Innate Immune System—HLA-C—psoriatic arthritis	0.000152	0.00965	CbGpPWpGaD
Probenecid—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000136	0.0136	CcSEcCtD
Probenecid—SLC16A7—tendon—psoriatic arthritis	0.000124	0.0473	CbGeAlD
Probenecid—PANX1—Innate Immune System—NOD2—psoriatic arthritis	0.000112	0.0071	CbGpPWpGaD
Probenecid—PANX1—Immune System—REL—psoriatic arthritis	9.6e-05	0.00611	CbGpPWpGaD
Probenecid—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	9.47e-05	0.00948	CcSEcCtD
Probenecid—PANX1—Innate Immune System—HLA-B—psoriatic arthritis	8.97e-05	0.00571	CbGpPWpGaD
Probenecid—PANX1—Immune System—HLA-C—psoriatic arthritis	8.83e-05	0.00562	CbGpPWpGaD
Probenecid—Alopecia—Betamethasone—psoriatic arthritis	8.83e-05	0.00884	CcSEcCtD
Probenecid—Alopecia—Dexamethasone—psoriatic arthritis	8.83e-05	0.00884	CcSEcCtD
Probenecid—ABCC5—tendon—psoriatic arthritis	8.69e-05	0.0331	CbGeAlD
Probenecid—Anaphylactic shock—Prednisolone—psoriatic arthritis	8.51e-05	0.00852	CcSEcCtD
Probenecid—Flushing—Prednisone—psoriatic arthritis	8.08e-05	0.00809	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	8.03e-05	0.00804	CcSEcCtD
Probenecid—PANX1—Innate Immune System—CRP—psoriatic arthritis	7.93e-05	0.00504	CbGpPWpGaD
Probenecid—SLC16A1—tendon—psoriatic arthritis	7.91e-05	0.0301	CbGeAlD
Probenecid—Anaphylactic shock—Triamcinolone—psoriatic arthritis	7.82e-05	0.00783	CcSEcCtD
Probenecid—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	7.81e-05	0.00782	CcSEcCtD
Probenecid—Haematuria—Methotrexate—psoriatic arthritis	7.72e-05	0.00773	CcSEcCtD
Probenecid—Alopecia—Prednisone—psoriatic arthritis	7.69e-05	0.0077	CcSEcCtD
Probenecid—Pain—Prednisolone—psoriatic arthritis	7.27e-05	0.00728	CcSEcCtD
Probenecid—Anaphylactic shock—Dexamethasone—psoriatic arthritis	7.1e-05	0.00711	CcSEcCtD
Probenecid—Anaphylactic shock—Betamethasone—psoriatic arthritis	7.1e-05	0.00711	CcSEcCtD
Probenecid—Anaemia—Prednisone—psoriatic arthritis	7e-05	0.00701	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—psoriatic arthritis	6.88e-05	0.00688	CcSEcCtD
Probenecid—Anorexia—Dexamethasone—psoriatic arthritis	6.77e-05	0.00677	CcSEcCtD
Probenecid—Anorexia—Betamethasone—psoriatic arthritis	6.77e-05	0.00677	CcSEcCtD
Probenecid—Urticaria—Prednisolone—psoriatic arthritis	6.76e-05	0.00677	CcSEcCtD
Probenecid—Pain—Triamcinolone—psoriatic arthritis	6.69e-05	0.0067	CcSEcCtD
Probenecid—PANX1—Immune System—NOD2—psoriatic arthritis	6.5e-05	0.00413	CbGpPWpGaD
Probenecid—Alopecia—Methotrexate—psoriatic arthritis	6.43e-05	0.00643	CcSEcCtD
Probenecid—Hypersensitivity—Prednisolone—psoriatic arthritis	6.27e-05	0.00628	CcSEcCtD
Probenecid—Urticaria—Triamcinolone—psoriatic arthritis	6.22e-05	0.00622	CcSEcCtD
Probenecid—Urticaria—Methylprednisolone—psoriatic arthritis	6.2e-05	0.00621	CcSEcCtD
Probenecid—Body temperature increased—Triamcinolone—psoriatic arthritis	6.18e-05	0.00619	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—psoriatic arthritis	6.18e-05	0.00619	CcSEcCtD
Probenecid—Decreased appetite—Betamethasone—psoriatic arthritis	6.17e-05	0.00618	CcSEcCtD
Probenecid—Decreased appetite—Dexamethasone—psoriatic arthritis	6.17e-05	0.00618	CcSEcCtD
Probenecid—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	6.17e-05	0.00393	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	6.13e-05	0.0039	CbGpPWpGaD
Probenecid—Pain—Dexamethasone—psoriatic arthritis	6.07e-05	0.00608	CcSEcCtD
Probenecid—Pain—Betamethasone—psoriatic arthritis	6.07e-05	0.00608	CcSEcCtD
Probenecid—ABCC4—tendon—psoriatic arthritis	6.03e-05	0.0229	CbGeAlD
Probenecid—SLC22A5—skin of body—psoriatic arthritis	5.94e-05	0.0226	CbGeAlD
Probenecid—Anorexia—Prednisone—psoriatic arthritis	5.89e-05	0.0059	CcSEcCtD
Probenecid—Anaemia—Methotrexate—psoriatic arthritis	5.85e-05	0.00586	CcSEcCtD
Probenecid—ABCC2—tendon—psoriatic arthritis	5.83e-05	0.0222	CbGeAlD
Probenecid—Hypersensitivity—Triamcinolone—psoriatic arthritis	5.76e-05	0.00577	CcSEcCtD
Probenecid—Hypersensitivity—Methylprednisolone—psoriatic arthritis	5.75e-05	0.00576	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—psoriatic arthritis	5.67e-05	0.00567	CcSEcCtD
Probenecid—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	5.64e-05	0.00359	CbGpPWpGaD
Probenecid—Urticaria—Dexamethasone—psoriatic arthritis	5.64e-05	0.00565	CcSEcCtD
Probenecid—Urticaria—Betamethasone—psoriatic arthritis	5.64e-05	0.00565	CcSEcCtD
Probenecid—Dizziness—Prednisolone—psoriatic arthritis	5.63e-05	0.00563	CcSEcCtD
Probenecid—Body temperature increased—Dexamethasone—psoriatic arthritis	5.61e-05	0.00562	CcSEcCtD
Probenecid—Body temperature increased—Betamethasone—psoriatic arthritis	5.61e-05	0.00562	CcSEcCtD
Probenecid—Pruritus—Triamcinolone—psoriatic arthritis	5.54e-05	0.00554	CcSEcCtD
Probenecid—Pruritus—Methylprednisolone—psoriatic arthritis	5.52e-05	0.00553	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—psoriatic arthritis	5.37e-05	0.00538	CcSEcCtD
Probenecid—Dermatitis—Prednisolone—psoriatic arthritis	5.36e-05	0.00537	CcSEcCtD
Probenecid—Headache—Prednisolone—psoriatic arthritis	5.33e-05	0.00534	CcSEcCtD
Probenecid—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	5.25e-05	0.00334	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—CRP—psoriatic arthritis	5.22e-05	0.00332	CbGpPWpGaD
Probenecid—PANX1—Immune System—HLA-B—psoriatic arthritis	5.22e-05	0.00332	CbGpPWpGaD
Probenecid—Dizziness—Triamcinolone—psoriatic arthritis	5.17e-05	0.00518	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—psoriatic arthritis	5.17e-05	0.00517	CcSEcCtD
Probenecid—Dizziness—Methylprednisolone—psoriatic arthritis	5.16e-05	0.00517	CcSEcCtD
Probenecid—ABCC1—tendon—psoriatic arthritis	5.14e-05	0.0195	CbGeAlD
Probenecid—Nausea—Prednisolone—psoriatic arthritis	5.05e-05	0.00506	CcSEcCtD
Probenecid—Pruritus—Betamethasone—psoriatic arthritis	5.02e-05	0.00503	CcSEcCtD
Probenecid—Pruritus—Dexamethasone—psoriatic arthritis	5.02e-05	0.00503	CcSEcCtD
Probenecid—Vomiting—Triamcinolone—psoriatic arthritis	4.97e-05	0.00498	CcSEcCtD
Probenecid—Vomiting—Methylprednisolone—psoriatic arthritis	4.96e-05	0.00497	CcSEcCtD
Probenecid—Dermatitis—Triamcinolone—psoriatic arthritis	4.93e-05	0.00493	CcSEcCtD
Probenecid—Anorexia—Methotrexate—psoriatic arthritis	4.92e-05	0.00493	CcSEcCtD
Probenecid—Dermatitis—Methylprednisolone—psoriatic arthritis	4.92e-05	0.00492	CcSEcCtD
Probenecid—Urticaria—Prednisone—psoriatic arthritis	4.91e-05	0.00492	CcSEcCtD
Probenecid—Headache—Triamcinolone—psoriatic arthritis	4.9e-05	0.00491	CcSEcCtD
Probenecid—Headache—Methylprednisolone—psoriatic arthritis	4.89e-05	0.0049	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—psoriatic arthritis	4.89e-05	0.00489	CcSEcCtD
Probenecid—Dizziness—Betamethasone—psoriatic arthritis	4.69e-05	0.0047	CcSEcCtD
Probenecid—Dizziness—Dexamethasone—psoriatic arthritis	4.69e-05	0.0047	CcSEcCtD
Probenecid—Nausea—Triamcinolone—psoriatic arthritis	4.65e-05	0.00465	CcSEcCtD
Probenecid—Nausea—Methylprednisolone—psoriatic arthritis	4.64e-05	0.00464	CcSEcCtD
Probenecid—PANX1—Immune System—CRP—psoriatic arthritis	4.62e-05	0.00294	CbGpPWpGaD
Probenecid—Hypersensitivity—Prednisone—psoriatic arthritis	4.55e-05	0.00456	CcSEcCtD
Probenecid—SLC22A5—tendon—psoriatic arthritis	4.52e-05	0.0172	CbGeAlD
Probenecid—Vomiting—Dexamethasone—psoriatic arthritis	4.51e-05	0.00452	CcSEcCtD
Probenecid—Vomiting—Betamethasone—psoriatic arthritis	4.51e-05	0.00452	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—psoriatic arthritis	4.49e-05	0.0045	CcSEcCtD
Probenecid—Dermatitis—Dexamethasone—psoriatic arthritis	4.47e-05	0.00448	CcSEcCtD
Probenecid—Dermatitis—Betamethasone—psoriatic arthritis	4.47e-05	0.00448	CcSEcCtD
Probenecid—Headache—Betamethasone—psoriatic arthritis	4.45e-05	0.00445	CcSEcCtD
Probenecid—Headache—Dexamethasone—psoriatic arthritis	4.45e-05	0.00445	CcSEcCtD
Probenecid—PANX1—Immune System—HLA-DRB1—psoriatic arthritis	4.42e-05	0.00281	CbGpPWpGaD
Probenecid—Pain—Methotrexate—psoriatic arthritis	4.42e-05	0.00442	CcSEcCtD
Probenecid—Pruritus—Prednisone—psoriatic arthritis	4.37e-05	0.00438	CcSEcCtD
Probenecid—ALB—Folate Metabolism—CRP—psoriatic arthritis	4.25e-05	0.0027	CbGpPWpGaD
Probenecid—Nausea—Betamethasone—psoriatic arthritis	4.22e-05	0.00422	CcSEcCtD
Probenecid—Nausea—Dexamethasone—psoriatic arthritis	4.22e-05	0.00422	CcSEcCtD
Probenecid—Urticaria—Methotrexate—psoriatic arthritis	4.1e-05	0.00411	CcSEcCtD
Probenecid—Dizziness—Prednisone—psoriatic arthritis	4.09e-05	0.00409	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—psoriatic arthritis	4.08e-05	0.00409	CcSEcCtD
Probenecid—Vomiting—Prednisone—psoriatic arthritis	3.93e-05	0.00394	CcSEcCtD
Probenecid—Dermatitis—Prednisone—psoriatic arthritis	3.89e-05	0.0039	CcSEcCtD
Probenecid—Headache—Prednisone—psoriatic arthritis	3.87e-05	0.00388	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—psoriatic arthritis	3.81e-05	0.00381	CcSEcCtD
Probenecid—Nausea—Prednisone—psoriatic arthritis	3.67e-05	0.00368	CcSEcCtD
Probenecid—Pruritus—Methotrexate—psoriatic arthritis	3.66e-05	0.00366	CcSEcCtD
Probenecid—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	3.65e-05	0.00232	CbGpPWpGaD
Probenecid—Dizziness—Methotrexate—psoriatic arthritis	3.42e-05	0.00342	CcSEcCtD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	3.4e-05	0.00216	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—CRP—psoriatic arthritis	3.38e-05	0.00215	CbGpPWpGaD
Probenecid—Vomiting—Methotrexate—psoriatic arthritis	3.28e-05	0.00329	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—psoriatic arthritis	3.25e-05	0.00326	CcSEcCtD
Probenecid—Headache—Methotrexate—psoriatic arthritis	3.24e-05	0.00324	CcSEcCtD
Probenecid—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	3.09e-05	0.00197	CbGpPWpGaD
Probenecid—Nausea—Methotrexate—psoriatic arthritis	3.07e-05	0.00307	CcSEcCtD
Probenecid—ALB—Vitamin B12 Metabolism—TNF—psoriatic arthritis	2.36e-05	0.0015	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—NOS2—psoriatic arthritis	2.25e-05	0.00143	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TNF—psoriatic arthritis	1.92e-05	0.00122	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NOS2—psoriatic arthritis	1.68e-05	0.00107	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—TNF—psoriatic arthritis	1.53e-05	0.000973	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	1.46e-05	0.000929	CbGpPWpGaD
Probenecid—ABCC5—Disease—NOS2—psoriatic arthritis	1.17e-05	0.000746	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NOS2—psoriatic arthritis	7.6e-06	0.000484	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	7.2e-06	0.000458	CbGpPWpGaD
Probenecid—ABCC1—Disease—NOS2—psoriatic arthritis	6.77e-06	0.000431	CbGpPWpGaD
